A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Kevin DAmour.

Business address: C/O Brooklyn Immunotherapeutics, Inc., 140 58 Th Street, Building A, Suite 2100, Brooklyn, NY, 11220
Top holdings (ownership): ERNA

Get insider transactions for this reporting owner

Kevin DAmour has filed 5 SEC EDGAR filings since 30 Jun 2021

Recent SEC filings for Kevin DAmour including 4, 4/A, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	FORM 4	29 Jun 2022	28 Jun 2022	001-11460
4/A	Open 4/A document	View SEC filing for 4/A	FORM 4/A	17 Mar 2022	11 Mar 2022	001-11460
4	Open 4 document	View SEC filing for 4	FORM 4	15 Mar 2022	11 Mar 2022	001-11460
4	Open 4 document	View SEC filing for 4	FORM 4	30 Jun 2021	28 Jun 2021	001-11460
3	Open 3 document	View SEC filing for 3	FORM 3	30 Jun 2021	28 Jun 2021	001-11460

Kevin DAmour files with the SEC under CIK 0001870486. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.